Wockhardt share news, announcements and annual reports

NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap

Wockhardt Limited · Face value ₹5 · Listed Feb 2000

₹1,896.50₹4.60 (0.24%)BSE ₹1,892.15

Share price at the NSE close on 2 Nov 2026. Previous close ₹1,901.10.

2 Nov: open ₹1,903.10, high ₹1,915.00, low ₹1,864.10

52-week range of traded prices to 2 Nov 2026

₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026

Market cap: ₹30,817 Cr311th largest listed
P/E: 75.16
P/B: 5.97
Dividend yield: Nonein the last 12 months
ROE: 8.4%
ROCE: 7.0%
Debt to equity: 0.39
Volume, NSE: 6,06,59351.5% delivered

Wockhardt share news and announcements

1,014 announcements, routine notices left out, newest first. Page 12 of 21.

Nov 2016
- 10 Nov · Dividend
  Board of Directors in its meeting held on November 10, 2016, have declared an Interim Dividend of Rs. 10 per Equity Share of face value of Rs. 5/- each i.e. @ 200 % for the Financial Year 2016-17.
- 10 Nov · Board meeting
  Outcome of Board Meeting of the Company held on November 10, 2016.
- 10 Nov · Results
  Financial results for the period ended September 30, 2016.
- 1 Nov · Corporate action
  Company has fixed Record Date as November 19, 2016 for the purpose of interim dividend
Oct 2016
- 28 Oct · Board meeting
  Inter-alia, to consider & approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2016; issuance of Masala Bonds and declaration of interim dividend, if any. It is further informed that pursuant to Regulation 42 of the Listing Regulations, the Record Date for payment of interim dividend, if declared, will be November 19, 2016. Further, please note that pursuant to Company s code of conduct for regulating, monitoring, reporting trading by designated persons, the Trading window for dealing in the shares of the Company will be closed from October 29, 2016 to November 12, 2016 (both days inclusive). The Trading Window shall re-open with effect from November 13, 2016.
- 3 Oct · Updates
  U.S. Food and Drug Administration ( USFDA ) on September 30, 2016 has posted on its website an update on the above referred matter and excluded the product Ceftriazone Sodium from Import Alert. This will enable the Company to manufacture and sell Ceftriazone API and formulation to US market.
Sep 2016
- 29 Sep · Updates
  Inspection of the manufacturing unit at L-1, Chikalthana, Aurangabad, Maharastra by UK MHRA has since been completed without any critical observations and the approval status of the said unit continues.
- 16 Sep · News Verification
  Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "USFDA clears Chikalthana Plant of Wockhardt." The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Wockhardt Limited has submitted their response.
- 16 Sep · News Verification
  Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "USFDA clears Chikalthana Plant of Wockhardt".In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
Aug 2016
- 29 Aug · Meeting
  Proceedings of Annual General Meeting (AGM) of the Company held on August 13, 2016.
- 13 Aug · Regulation 44(3) of SEBI (LODR), Reg., 2015
  Details of voting results of the Annual General Meeting of the Company held on August 13, 2016 along with the Scrutinizer s Report.
- 13 Aug · Meeting
  Proceedings of the Annual General Meeting of the Company held on August 13, 2016.
- 13 Aug · Results
  Standalone & consolidated financial results along with the Limited Review Report for the period ended June 30, 2016.
- 13 Aug · Board meeting
  Press release dated August 13, 2016 titled "Wockhardt Q1FY17 Net Sales at Rs.1,091 crore and PAT at Rs.16 crore".
- 8 Aug · News Verification
  Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "Wockhardt gets import alert from US FDA". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Wockhardt Limited has submitted their response.
- 8 Aug · Updates
  U.S. Food and Drug Administration ( USFDA ) has updated Import Alert 66-40 on its website on the Company's API (Active Pharmaceutical Ingredients) Unit located in Ankleshwar, Gujarat. Company await official communication from US FDA in this matter. The Company has already initiated required steps to address the concerns raised by USFDA and is putting all efforts to resolve the matter.
- 8 Aug · News Verification
  Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "Wockhardt gets import alert from US FDA". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
Jul 2016
- 28 Jul · Board meeting
  Inter-alia, to consider & approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2016.
- 28 Jul · Business
  Share Allotment Committee of Board of Directors of the Company has allotted 39,125 equity shares of face value of Rs.5/- each on 28th July, 2016, pursuant to exercise of employee stock options under Employee Stock Options Scheme - 2011 of the Company.In view of the above, the paid-up equity share capital of the Company will accordingly increase from Rs. 552,544,515/- (110,508,903 equity share of Rs.5/- each) to Rs.552,740,140/- (110,548,028 equity shares of Rs.5/- each).
- 21 Jul · News Verification
  Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "Wockhardt gets establishment inspection RPT for Chikalthana Unit". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Wockhardt Limited has submitted their response.
- 21 Jul · News Verification
  Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "Wockhardt gets establishment inspection RPT for Chikalthana Unit".In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
- 14 Jul · Meeting
  Notice of Annual General Meeting of the members of the company to be held on August 13, 2016.
- 7 Jul · Legal
  Exchange had sought clarification from the Company with respect to announcement dated July 01, 2016, regarding the Company has given Corporate Guarantee to secure Term loan of US$ 250 Million facility availed by Wockhardt Bio AG, a subsidiary of the Company. On the basis of above, reply of the Company is attached
- 5 Jul · Legal
  Exchange has sought clarification from Wockhardt Limited with respect to announcement dated July 01, 2016, regarding Company has given Corporate Guarantee to secure Term loan of US$ 250 Million facility availed by Wockhardt Bio AG, a subsidiary of the Company. On basis of above the Company is required to clarify following:1. Whether the promoter/ promoter group/ group companies have any interest in this transaction? If yes, nature of interest and details thereof and whether the same is done at arms length ;2. Brief details of such guarantee or indemnity or becoming a surety viz. brief details of agreement entered (if any) including significant terms and conditions, including amount of guarantee;3. Impact of such guarantees or indemnity or surety on listed entity.The response of the Company is awaited.
- 1 Jul · Meeting
  Register of Members and Share Transfer Books of the Company shall remain closed from August 6, 2016 to August 13, 2016 (both days inclusive) for the purpose of dividend and Annual General Meeting of the Company scheduled to be held on August 13, 2016 and declaration of dividend on Preference Shares.
- 1 Jul · Updates
  In accordance with the Company's Policy for determining Materiality of Events, this is to inform the Exchanges that Wockhardt Limited ( the Company ) has given Corporate Guarantee to secure Term loan of US$ 250 Million facility availed by Wockhardt Bio AG, a subsidiary of the Company.
May 2016
Apr 2016
- 22 Apr · Board meeting
  Inter-alia, to consider & approve the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2016; and issuance of Non-Convertible Debentures on private placement basis.
- 7 Apr · Disclosure
  Dr. Habib Khorakiwala has submitted to the Exchange vide letter dated April 6, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Feb 2016
Jan 2016
- 22 Jan · Board meeting
  Inter-alia, to consider and approve the Unaudited Financial Results (standalone and consolidated) of the Company for the quarter and nine months ended 31st December, 2015.
- 21 Jan · Rating
  Credit Analysis & Research Ltd (CARE Rating) has reaffirmed the Company Rating for total Working Capital limit as "CARE AA" and "CARE A1+" for Long - Term Bank Facilities (Fund Based) and Short Term Bank Facilities (Non Fund Based) respectively.
- 15 Jan · Updates
  That inspection of our manufacturing unit at E-1/1, MIDC, Shendra, Aurangabad by US FDA has since been completed. US FDA has made 9 observations for which appropriate reply would be submitted to inspecting authority in due course.Further to inform you that Shendra manufacturing unit is a new facility and presently there are no supply of products from the said Unit to USA markets
- 15 Jan · Legal
  Exchange had sought clarification from Wockhardt Limited with respect to recent news item titled Wockhardt recalls 62,555 bottles of antibiotics in US.The Company has informed the Exchange that 'We have to inform you that the Company has earlier decided to recall, as a part of remedial measure the remaining batches in the US market that were manufactured prior to US FDA Import Alerts even though there was no evidence of risk to patient safety from these products. The same was informed to the Stock Exchanges on 28th April, 2015 by the Company. The recall stated in the said news item forms part of the same. Please note that as a part of standard practice, the Company has to inform to US FDA periodically the products actually received from the trade against such recall. Such periodic returns of products are reported by the media based on such information submitted to US FDA by the Company from time to time even though they are not additional recalls. The Company keeps the exchange informed about events, information etc. including price sensitive information in accordance with regulatory requirements. In present case, we do not have any important information / announcement to be shared.In the event that there is any development that requires disclosure, we will make the same in accordance with the requirements of Listing Regulations.
- 15 Jan · Legal
  Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "Wockhardt recalls 62,555 bottles of antibiotics in US". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under regulation 30 of Listing regulations. The response from the Company is awaited.
- 12 Jan · Updates
  Board of Directors of the Company have authorised the following Key Managerial Personnel for the determination of materiality of event/ information including making disclosures to the Stock Exchanges: 1) Dr. Murtaza Khorakiwala 2) Mr. Manas Datta 3) Mr. Narendra Singh
- 4 Jan · Rating
  India Ratings and Research Private Limited has assigned the Company's proposed Rs. 500 million commercial paper (CP)/short-term debt programme a Short-term rating of IND A1+'.
Dec 2015
Nov 2015
- 13 Nov · Business
  Press release dated November 13, 2015 titled "Wockhardt Q2FY16 Net Sales at Rs.1231 crore (YOY growth of 20%) and EBIDTA at 201 crore (YOY growth of 22%)".

Wockhardt share news and announcements

Nov 2016

Oct 2016

Sep 2016

Aug 2016

Jul 2016

May 2016

Apr 2016

Feb 2016

Jan 2016

Dec 2015

Nov 2015